Literature DB >> 7871949

Hematuria in sickle cell anemia--not always benign: evidence for excess frequency of sickle cell anemia in African Americans with renal cell carcinoma.

B W Baron1, R Mick, J M Baron.   

Abstract

Between 1952 and 1992, we identified 117 African Americans with renal cell carcinoma (RCC) at the University of Chicago. Three of these had sickle cell disease (SS) and 11 had presumed sickle trait (AS). Based on genotype frequencies, these represented a 16.7-fold excess of SS patients (p < 0.0001), but the incidence of AS patients was as expected. In addition, the median age for the SS patients at presentation with RCC (36 years) was significantly less (p = 0.04) than for the AS patients (55 years). We have found no prior reports of SS in RCC patients and suggest that chronic renal injury from sickling and possible immunosuppressive effects of multiple red cell transfusions may be risk factors. We also suggest the need to be aware of the possibility of RCC in SS patients who may have hematuria solely related to sickling.

Entities:  

Mesh:

Year:  1994        PMID: 7871949     DOI: 10.1159/000204199

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  2 in total

1.  Is renal medullary carcinoma the seventh nephropathy in sickle cell disease? A multi-center Nigerian survey.

Authors:  Madu Anazoeze; Galadincci Najibah; Umar Garba; Abdulahi Shehu; Fowodu Florence; Hassan Abdulaziz; Inyama Marcus; Akinpelu Oluwaseun; Nwagha Theresa; Ibegbulam Obike; Ocheni Sunday; Emodi Ifeoma; Ikefuna Anthony; Chukwu Barth; Okocha Chide; Orkuma Joseph; Iheanacho Malachy; Korubo Kaladada; Anike Uche; Agu Kingsley; Nonyelu Charles; Ugwu Angela; Duru Augustin; Anigbo Chikwudi; Eze Alozie; Ololo Uchenna; Omoti Caroline; Agwu Obineche; Okpala Iheanyi
Journal:  Afr Health Sci       Date:  2016-06       Impact factor: 0.927

Review 2.  Sickle cell nephropathy: an update on pathophysiology, diagnosis, and treatment.

Authors:  Essa Hariri; Anthony Mansour; Andrew El Alam; Yazan Daaboul; Serge Korjian; Sola Aoun Bahous
Journal:  Int Urol Nephrol       Date:  2018-01-30       Impact factor: 2.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.